[Go to the reading desk](#reading-desk)

[Carefree When peptide therapy needs explaining](/)

Room for a question.

[What is it?](/quick-brief/) [Care in Carefree?](/carefree-desk/) [What will it cost?](/money-desk/) [What needs a check?](/safety-desk/) [What can I ask?](/help-desk/)

The source desk

# Where can I check the answer?

Choose a source that answers the question you actually have.

An approval question, a licence question, and a payment question need different records. Open the relevant source and keep the product or person's exact name beside you.

## What does approved mean?

FDA is short for Food and Drug Administration; its work includes US medicine review.

As of September 26, 2026, FDA registration or a drug-directory entry does not mean a medicine is FDA-approved.

Use this source to see what approval means. Ask for the approval record for the exact medicine, rather than just a directory code.

Source note

[FDA: approval explained](https://www.fda.gov/consumers/consumer-updates/it-really-fda-approved)

## Who regulates the person?

As of October 3, 2026, Arizona uses separate licensing boards for doctors with MD and DO after their names.

Ask which title the doctor holds, then use the matching search.

Source note

[Arizona MD search](https://www.azmd.gov/DoctorSearch/DoctorSearch)

[Arizona DO search](https://azdo.gov/find-your-do)

## What are the online-care rules?

Telehealth means care at a distance.

Arizona generally requires informed agreement before telehealth and protects the privacy of your records, as of October 3, 2026.

An examination before prescribing can often happen through telehealth, but the clinician must follow the rules for the medicine and their profession.

Ask: What will you examine by video? Will I need any tests or a visit in person? How will you keep my records private? The linked law explains the rules; the screen desk explains what to ask about your visit.

Source note

[Arizona: telehealth requirements](https://www.azleg.gov/ars/36/03602.htm)

## What is the temporary Medicare programme?

As of September 26, 2026, Medicare's GLP-1 Bridge is a temporary programme outside normal Part D coverage.

Part D is Medicare's drug benefit. The official page is the place to check programme terms and eligibility.

Source note

[Medicare: Bridge details](https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge)

## How do I report a suspected medicine problem?

Both patients and health professionals may send reports to the FDA's MedWatch programme.

Keep the medicine name and the details you want to report. For care about symptoms, ask the clinician responsible for your treatment.

Source note

[FDA: the MedWatch programme](https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program)

Another question

[What does the evidence actually say?](/research-notes/)

Medical jargon can be questioned

## Can you explain that?

Ask for the answer in plain words, then ask for it in writing if that helps.

[Find words for the next visit](/help-desk/)

Keep this guide at hand for clear questions; these desks neither provide clinic care nor sell treatment.

[Check the sources](/source-desk/) [Read this page as text](/source-desk/index.md) [Guide index](/llms.txt) [Back to the welcome desk](/)